3- (4- bromoacetamidobenzyl)- 2- (1,4,7,10- tetraazacyclodecane- 1,4,7- triacetic acid-(10-acetamido))propanamide
used to derivatize monoclonal antibodies; structure in first source
Also Known As:
bromoacetyl-DOTA-Ph-Al
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results